These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 19520880)

  • 1. Novel therapeutic agents and strategies for the management of chronic kidney disease mineral and bone disorder.
    Connor A
    Postgrad Med J; 2009 May; 85(1003):274-9. PubMed ID: 19520880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D retains an important role in the pathogenesis and management of secondary hyperparathyroidism in chronic renal failure.
    Cozzolino M; Gallieni M; Brancaccio D; Arcidiacono T; Bianchi G; Vezzoli G
    J Nephrol; 2006; 19(5):566-77. PubMed ID: 17136683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of secondary hyperparathyroidism in chronic kidney disease and the direct costs of treatment.
    Joy MS; Karagiannis PC; Peyerl FW
    J Manag Care Pharm; 2007 Jun; 13(5):397-411. PubMed ID: 17605511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges in the therapy of secondary hyperparathyroidism.
    Wood C; González EA; Martin KJ
    Ther Apher Dial; 2005 Feb; 9(1):4-8. PubMed ID: 15828898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of renal bone disease treatment in dialysis patients.
    Johnson CA; McCarthy J; Bailie GR; Deane J; Smith S
    Am J Kidney Dis; 2002 Jun; 39(6):1270-7. PubMed ID: 12046041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Renal osteodystrophy (3); its treatment in dialysis patients].
    Ghitu S; Oprisiu R; Benamar L; Said S; Tataru Albu A; Arsenescu I; el Esper N; Morinière P; Fournier A
    Nephrologie; 2000; 21(8):413-24. PubMed ID: 11213385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of cinacalcet in management of mineral bone disorder in chronic kidney disease (control of calcium, phosphorus and parathyroid hormone).
    Tahara H
    Ther Apher Dial; 2008 Oct; 12 Suppl 1():S27-33. PubMed ID: 19032524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Battleground: chronic kidney disorders mineral and bone disease--calcium obsession, vitamin d, and binder confusion.
    Kovesdy CP; Mehrotra R; Kalantar-Zadeh K
    Clin J Am Soc Nephrol; 2008 Jan; 3(1):168-73. PubMed ID: 18045858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mineral metabolism and bone abnormalities in children with chronic renal failure.
    Sanchez CP
    Rev Endocr Metab Disord; 2008 Jun; 9(2):131-7. PubMed ID: 18175221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on the treatment of chronic kidney disease-mineral and bone disorder.
    Bover J; Farré N; Andrés E; Canal C; Olaya MT; Alonso M; Quílez B; Ballarín J
    J Ren Care; 2009 Mar; 35 Suppl 1():19-27. PubMed ID: 19222727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Management of renal osteopathy in patients with chronic dialysis].
    Kiss D; Brunner FP
    Schweiz Med Wochenschr; 1996 Oct; 126(42):1792-8. PubMed ID: 8966512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of vitamin D analogs in chronic renal failure.
    Kim G; Sprague SM
    Adv Ren Replace Ther; 2002 Jul; 9(3):175-83. PubMed ID: 12203199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies to minimize bone disease in renal failure.
    Martin KJ; González EA
    Am J Kidney Dis; 2001 Dec; 38(6):1430-6. PubMed ID: 11728986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteodystrophy developing spontaneously in the course of chronic renal failure.
    Stanbury SW; Lumb GA; Mawer EB
    Arch Intern Med; 1969 Sep; 124(3):274-81. PubMed ID: 5806041
    [No Abstract]   [Full Text] [Related]  

  • 15. [Physiopathology and therapy of renal osteodystrophy and secondary hyperparathyroidism].
    Fukagawa M
    Nihon Naika Gakkai Zasshi; 1999 Jul; 88(7):1245-50. PubMed ID: 10465972
    [No Abstract]   [Full Text] [Related]  

  • 16. [Bone disease in chronic renal failure and its modern therapy].
    Dusilová Sulková S
    Vnitr Lek; 2011; 57(7-8):620-5. PubMed ID: 21877595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Vitamin D analogues for osteodystrophy in chronic kidney disease.
    Cunningham J
    Pediatr Nephrol; 2004 Jul; 19(7):705-8. PubMed ID: 15141342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The bone and mineral disorder of children undergoing chronic peritoneal dialysis.
    Borzych D; Rees L; Ha IS; Chua A; Valles PG; Lipka M; Zambrano P; Ahlenstiel T; Bakkaloglu SA; Spizzirri AP; Lopez L; Ozaltin F; Printza N; Hari P; Klaus G; Bak M; Vogel A; Ariceta G; Yap HK; Warady BA; Schaefer F;
    Kidney Int; 2010 Dec; 78(12):1295-304. PubMed ID: 20811335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decrease in thoracic vertebral bone attenuation with calcium-based phosphate binders in hemodialysis.
    Raggi P; James G; Burke SK; Bommer J; Chasan-Taber S; Holzer H; Braun J; Chertow GM
    J Bone Miner Res; 2005 May; 20(5):764-72. PubMed ID: 15824849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vitamin D metabolism and chronic kidney disease].
    Honda H; Sanada D; Akizawa T
    Clin Calcium; 2006 Jul; 16(7):1143-46. PubMed ID: 16816474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.